Conference Call with Galaxy Surfactants Management and Analysts on Q3FY25 Performance and Outlook. Listen to the full earnings transcript.
Specialty Chemicals company Galaxy Surfactants announced Q3FY25 results Total Revenue: Rs 1,045.7 crore compared to Rs 946.9 crore during Q3FY24, change 10.4%. EBITDA: Rs 109.5 crore compared to Rs 118.9 crore during Q3FY24, change -7.8%. EBITDA margin: 10.5% for Q3FY25. PAT: Rs 64.6 crore compared to Rs 71.4 crore during Q3FY24, change -9.5%. PAT margin: 6.2% for Q3FY25. K. Natarajan, Managing Director, Galaxy Surfactants, said: “Q3FY25 has been a slow quarter for us primarily impacted by the slowdown in India. While the festive season failed to reignite demand in India, an improving supply chain scenario supported by a stable inflationary environment ensured QoQ improvement in our AMET Volumes. Despite seasonal holidays, demand momentum remained strong in ROW markets. At first glance, the quarter may appear weak, due to the decline in EBITDA/MT, which stood at Rs 19,269/MT for 9MFY25. However, multiple steps have been taken to ensure improvement going ahead. From new product launches to pick up in premium specialties, we strongly believe the groundwork laid over the last 2 years will yield positive results. While Q4FY25 mayremain muted given India's cyclical slowdown, there is a strong probability of demand improving from Q1FY26. Despite the current pessimism, we remain confident this is a blip and that the structural growth story remains intact” Result PDF
Conference Call with Galaxy Surfactants Management and Analysts on Q2FY25 Performance and Outlook. Listen to the full earnings transcript.
Specialty Chemicals company Galaxy Surfactants announced Q2FY25 results Total Revenue: Rs 1,071.7 crore compared to Rs 985.8 crore during Q2FY24, change 8.7%. EBITDA: Rs 136.3 crore compared to Rs 127.6 crore during Q2FY24, change 6.9%. EBITDA Margin: 12.7% for Q2FY25. PAT: Rs 84.7 crore compared to Rs 77.4 crore during Q2FY24, change 9.4%. PAT margin: 7.9% for Q2FY25. K. Natarajan, Managing Director, Galaxy Surfactants, said: “Q2FY25 was a mixed quarter for us. While this Quarter has seen sequential Volume growth as well as YoY mid single digit volume growth driven primarily by our Specialty Care products; a slowdown in India remains an area of concern. The significant uptick in raw material prices combined with supply chain challenges did disturb momentum in this quarter and remains a major risk going ahead. While EBITDA/MT came in below the guided band of Rs 20,500-21,500 at 20,097/MT; improvement in premium specialties business should aid margins going ahead. We strongly believe, the sequential improvement seen in this quarter, is a major positive and the same should continue going ahead.” Result PDF